These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7193277)

  • 41. Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients.
    Frustaci S; Barzan L; Tumolo S; Comoretto R; Quadu G; Galligioni E; Lorenzini M; Crivellari D; Caruso G; Piccinin G
    Cancer; 1986 Mar; 57(6):1118-23. PubMed ID: 3943035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Paredes J; Hong WK; Felder TB; Dimery IW; Choksi AJ; Newman RA; Castellanos AM; Robbins KT; McCarthy K; Atkinson N
    J Clin Oncol; 1988 Jun; 6(6):955-62. PubMed ID: 2836565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcomes of platinum-based chemotherapy plus cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck: comparison between platinum-sensitive and platinum-resistant patients.
    Sato H; Tsukahara K; Okamoto I; Katsube Y; Shimizu A; Kondo T; Hanyu K; Fushimi C; Okada T; Miura K
    Acta Otolaryngol; 2019 Feb; 139(2):201-205. PubMed ID: 30794080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combination chemotherapy with cis-diammine-di-chloro-platinum (II) and bleomycin in advanced head and neck cancer].
    Sasaki T; Ibuka T; Imai K; Sakai Y; Hayakawa M; Tanikawa Y; Miyashita H; Komiya Y; Matsuda T
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1412-7. PubMed ID: 6191715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Espinosa E; Zamora P; Millá A; Morales S; Molina R; Mira M; González Barón M;
    Head Neck; 2002 Dec; 24(12):1054-9. PubMed ID: 12454943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck.
    Thödtmann F; Theiss F; Kemmerich M; Heinrich B; Laubenbacher C; Quasthoff S; Kau R; Herzog M; Diergarten K; Hanauske AR
    Ann Oncol; 1998 Mar; 9(3):335-7. PubMed ID: 9602270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer.
    Jacobs C
    Recent Results Cancer Res; 1981; 76():290-5. PubMed ID: 7015433
    [No Abstract]   [Full Text] [Related]  

  • 49. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.
    Hehr T; Classen J; Belka C; Welz S; Schäfer J; Koitschev A; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1423-31. PubMed ID: 15817346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin alone or in combination with adriamycin in the treatment of patients with head and neck cancer relapsed after radiotherapy and/or surgery.
    Villar A; Farrus B; Giner P; Sedano E; Serradell J; de Caralt M
    Rev Esp Oncol; 1981; 28(3):395-412. PubMed ID: 6892263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.
    Chang PM; Tzeng CH; Chen MH; Tsao CJ; Su WC; Hwang WS; Chang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1477-84. PubMed ID: 21484308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
    Vokes EE; Haraf DJ; Brockstein BE; Weichselbaum RR
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):70-6. PubMed ID: 10210543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chemotherapy for unresectable recurrent or metastatic squamous cell carcinomas of the head and neck].
    Nishino H; Fujisawa Y; Kanazawa T; Ishikawa K; Miyata M; Ichimura K; Abe K; Tanaka H
    Nihon Jibiinkoka Gakkai Kaiho; 2000 Sep; 103(9):963-9. PubMed ID: 11070972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study.
    Kish JA; Benedetti JK; Balcerzak SP; Veith RW; Davis R; Pollock TW; Schuller DE; Ensley JF
    Cancer J Sci Am; 1999; 5(5):307-11. PubMed ID: 10526672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
    Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
    Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy for relapsed head and neck cancer: paclitaxel, cisplatin, and 5-fluorouracil in chemotherapy-naive patients. A dose-finding study.
    Benasso M; Numico G; Rosso R; Merlano M; Ricci I; Gentile A
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-46-S19-50. PubMed ID: 9427266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cis-diamminedichloride platinum(II), an effective agent in the treatment of epidermoid carcinoma of the esophagus. A preliminary report of an ongoing Southwest Oncology Group study.
    Panettiere FJ; Leichman L; O'Bryan R; Haas C; Fletcher W
    Cancer Clin Trials; 1981; 4(1):29-31. PubMed ID: 7194161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
    Glisson BS; Murphy BA; Frenette G; Khuri FR; Forastiere AA
    J Clin Oncol; 2002 Mar; 20(6):1593-9. PubMed ID: 11896109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.